The Good Manufacturing Practices (GMP) regulation, is contained in section 520 of the Food, Drug and Cosmetic Act. It requires that domestic or foreign manufacturers of medical devices intended for commercial distribution in the United States establish and follow a quality assurance (QA) program. The GMP rule is a flexible program in that it allows a quality assurance program which is appropriate for the specific devices. The regulation requires that specifications and controls be established for devices and that finished devices meet these specifications. In this way, the GMP regulation helps assure that medical devices are safe and effective.
Analysis of recalls and adverse reaction reports show that about half of reported device failures involve traditional GMP problems. Between 1985 and 1989, FDA compiled data through its recall database that demonstrated that 45 to 50 percent of all device recalls stemmed from poor product design (including problems with software). Congress, alarmed by this, asked FDA to identify enforcement mechanisms to address the issue. FDA responded that design controls or enhanced GMP controls were needed. As a result, Congress passed the Safe Medical Devices Act (SMDA) of 1990, which gives FDA authority to require good manufacturing practices necessary to ensure proper device design.
To act on this mandate, the FDA revised the GMP requirements for medical devices and incorporated them into a quality system regulation. The Quality System Regulation includes requirements related to the methods used in, and the facilities and controls used for, designing, manufacturing, packaging, labeling, storing, installing and servicing of medical devices intended for human use. The revised GMP Regulation was released as a final rule on October 7, 1996. The section that deals specifically with design controls is section 820.30 of Title 21, of the Code of Federal Regulations ("21 CFR"). 21 CFR 820.30 requires manufacturers to establish and maintain procedures to control and verify device design to ensure that design requirements are met. More specifically, it requires manufacturers to establish and maintain plans that describe or reference the design and development activities and indicate responsibility for their implementation. It further requires manufacturers to establish and maintain procedures to ensure that design requirements relating to a particular device are appropriate and address the intended use of the device, including the needs of users and patients. It also requires manufacturers to establish and maintain procedures to ensure that design output meets the design input requirements. The regulation is effective June 1, 1997.
( c ) Design input:
"Each manufacturer shall establish and maintain procedures to ensure that the design requirements relating to a device are appropriate and address the intended use of the device, including the needs of the users and patient."
( f ) Design verification:
"Each manufacturer shall establish and maintain procedures for verifying
the design input. Design verification shall confirm that the design output meets
the design input requirements."
( g ) Design validation:
"Design validation shall ensure that devices conform to defineduser needs and intended uses, and shall include testing of production units under actual or simulated use conditions."
"Design validation shall include...risk analysis...."
Human factors relevance: In addition to other hazards, risk analysis should
include use error as well. A risk analysis is appropriate for any device where
use error can lead to serious patient injury.
Updated April 22, 1998
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH